Emisphere Technologies Incorporated operates in the Pharmaceutical preparations sector. Emisphere Technologies, Inc. (Emisphere) is a biopharmaceutical company that focuses on a delivery of therapeutic molecules or nutritional supplements using its Eligen Technology. The Eligen Technology is applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The Company continues to develop product candidates in-house and the value of its Eligen Technology was demonstrated and improved through the progress made by its development partners Novo Nordisk A/S (Novo Nordisk) and Novartis Pharma AG (Novartis) on their respective product development programs. The Eligen Technology is a applicable oral drug delivery technology based on the use of synthetic chemical compounds known as Emisphere delivery agents, or carriers. In our complete report available for purchase the company is compared to: Novelos Therapeutics, Inc., Mannkind Corporation and Rexahn Pharmaceuticals Inc..